XE 991 dihydrochloride

CAS No. 122955-13-9

XE 991 dihydrochloride( XE-991 | XE991 )

Catalog No. M10900 CAS No. 122955-13-9

A potent, selective and orally active blocker of voltage-gated potassium channels Kv7 (KCNQ) that blocks KCNQ1, KCNQ2 and KCNQ2+KCNQ3 with Kd of 0.78, 0.7 and 0.6 uM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 Get Quote
10MG 140 Get Quote
25MG 267 Get Quote
50MG 494 Get Quote
100MG 716 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    XE 991 dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective and orally active blocker of voltage-gated potassium channels Kv7 (KCNQ) that blocks KCNQ1, KCNQ2 and KCNQ2+KCNQ3 with Kd of 0.78, 0.7 and 0.6 uM, respectively.
  • Description
    A potent, selective and orally active blocker of voltage-gated potassium channels Kv7 (KCNQ) that blocks KCNQ1, KCNQ2 and KCNQ2+KCNQ3 with Kd of 0.78, 0.7 and 0.6 uM, respectively; displays 14-fold less potency for KCNQ1+minK current with Kd of 11 uM, enhances hippocampal ACh release from rat brain slices (EC50=490 nM) and is a cognitive enhancer in vivo.Alzheimer Disease Discontinued.
  • In Vitro
    XE991 dihydrochloride possesses an EC50 of 490 nM for enhancement of [3H]ACh release from rat brain slices, and shows good in vivo potency and duration of action.
  • In Vivo
    ——
  • Synonyms
    XE-991 | XE991
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    Potassium Channel
  • Research Area
    Neurological Disease
  • Indication
    Alzheimer Disease

Chemical Information

  • CAS Number
    122955-13-9
  • Formula Weight
    449.37
  • Molecular Formula
    C26H20N2O.2HCl
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 11.11 mg/mL (24.72 mM)
  • SMILES
    O=C1C2=C(C=CC=C2)C(CC3=CC=NC=C3)(CC4=CC=NC=C4)C5=CC=CC=C15
  • Chemical Name
    10,10-bis(4-Pyridinylmethyl)-9(10H)-anthracenone dihydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zaczek R, et al. J Pharmacol Exp Ther. 1998 May;285(2):724-30. 2. Wang HS, et al. Mol Pharmacol. 2000 Jun;57(6):1218-23. 3. MacVinish LJ, et al. Mol Pharmacol. 2001 Oct;60(4):753-60. 4. Yeung SY, et al. Br J Pharmacol. 2005 Oct;146(4):585-95.
molnova catalog
related products
  • Lei-Dab 7

    High affinity, selective KCa2.2 (SK2) channel blocker (Kd = 3.8 nM). Exhibits >200-fold selectivity for KCa2.2 over KCa2.1, KCa2.3, KCa3.1, IK, Kv and Kir2.1. Increases theta-burst responses and increases LTP in rat hippocampal slices in vitro. Convulsive in vivo.

  • Azimilide

    A class ΙΙΙ antiarrhythmic agent that blocks hERG channel; blocks HERG channel at 0.1 and 1 Hz with IC50s of 1.4 uM and 5.2 uM respectively.

  • Kv2-IN-A1

    Kv2-IN-A1 is an inhibitor of Kv2.1 and Kv2.2.